
ABOUT ALEXANDRIA
Alexandria Real Estate Equities, Inc., Landlord of Choice to the Life Science Industry®, is the largest REIT focused principally on providing high-quality real estate for the life science industry. Located in the top life science markets around the globe, Alexandria’s world-class properties, highly specialized operations, and expansive network assist the life science industry in translating promising discoveries into important, safe, and effective products that benefit humankind.
ALEXANDRIA’S GLOBAL REACH

ALEXANDRIA’S WORLD-CLASS
CLIENT TENANT BASE
Pharmaceutical
Abbott Laboratories
Astellas Pharma US, Inc.
AstraZeneca plc
Baxter International, Inc.
GlaxoSmithKline plc
Johnson & Johnson
Merck & Company, Inc.
Novartis AG
Pfizer Inc.
Roche Holding Ltd.
Biotechnology
Alnylam Pharmaceuticals, Inc.
Amgen, Inc.
Amylin Pharmaceuticals, Inc.
Biogen Idec, Inc.
Celgene Corporation
Genentech, Inc.
Genzyme Corporation
Gilead Sciences, Inc.
Independent, Not-for-Profit, Universities
& Government
Bill & Melinda Gates Foundation
The Burnham Institute
Environmental Protection Agency
Fred Hutchinson Cancer Research Center
Massachusetts Institute of Technology
The National Institutes of Health
The Scripps Research Institute
University of California, San Francisco
University of Massachusetts
UMass Memorial Medical Center
University of Washington
Medical Device, Life Science Product,
Service & Biodefense
Applera Corporation
Bio-Rad Laboratories, Inc.
Becton, Dickinson and Company
Canon U.S. Life Sciences, Inc.
Invitrogen, Inc.
Laboratory Corporation of America
Monsanto Company
Qiagen N.V.
Quest Diagnostics Inc.
Siemens AG
Syngenta AG